SWISSDECODE SA

Their core work

SWISSDECODE is a Swiss deep-tech SME building automated DNA-based screening platforms for food supply chain authentication and pathogen detection. Their core product is a rapid, field-deployable DNA screening device capable of verifying food origin, detecting adulterants, and identifying pathogens — designed to work at the speed and scale industrial food chains require. They progressed from concept validation (DNAFoil, 2018) to a full ISO-certified automated platform (BEAMitup, 2020), and during the COVID-19 period extended their detection capabilities to coronavirus screening. Their value proposition is turning molecular biology into a practical industrial quality control tool, not a laboratory procedure.

What they specialise in

How they've shifted over time

SWISSDECODE entered H2020 in 2018 with a narrowly scoped feasibility study — DNAFoil — focused on the food fraud problem: can you rapidly screen DNA at a food supply chain checkpoint? That Phase 1 probe (EUR 50,000) apparently validated the concept, because they returned in 2020 with a EUR 2.5M Phase 2 project to build the full automated, ISO-certified platform. The keyword shift from the first to second project is telling: "DNA screening" and "automation" confirm the core mission scaled up, but the addition of "coronavirus detection" shows they recognized that the same molecular platform architecture is applicable to any detection target, not just food adulterants. The trajectory is clear: from a single-application food screening device toward a general-purpose automated molecular diagnostics platform.

SWISSDECODE is broadening from a food-sector tool into a horizontal diagnostics platform company — any organization needing fast, automated DNA or pathogen detection (food safety, public health, biosecurity) is a potential future collaboration or customer target.

How they like to work

SWISSDECODE has been a solo operator in H2020 — both projects were coordinated by them alone, with no recorded consortium partners, which is entirely typical of the SME Instrument scheme they used. This tells you they are a self-sufficient technology developer who drives their own roadmap rather than joining existing research consortia. If you want to partner with them, expect to engage them as a technology provider or licensing partner, not as a co-applicant in a large research consortium — at least based on their H2020 track record.

SWISSDECODE's H2020 participation was entirely through the SME Instrument, which funds single companies rather than consortia, so their formal EU network shows zero consortium partners across zero countries. Their real commercial and scientific network is not visible in this data and would need to be traced through their BEAMitup project publications, advisory boards, or commercial partnerships.

What sets them apart

SWISSDECODE occupies a rare position at the intersection of molecular biology and industrial automation — they are not a genomics research lab and not a food testing services company, but an instrument developer building the machine that sits on the factory floor. Their ISO-certification focus signals they understand that industry buyers need validated, audit-ready tools, not research prototypes. The pivot to coronavirus detection during BEAMitup shows platform thinking: whoever controls the detection hardware can swap targets, which is a strong moat in a world where new pathogens and food fraud types keep emerging.

Highlights from their portfolio

• BEAMitup
  At EUR 2,499,700 this is one of the largest individual SME Instrument Phase 2 grants, signaling the European Commission's confidence in their technology readiness, and the coronavirus detection angle gives it cross-sector reach well beyond food.
• DNAFoil
  The EUR 50,000 Phase 1 feasibility study that seeded the entire platform — a textbook SME Instrument progression from proof-of-concept to scaled product that ended in a 50x larger follow-on grant.